# Improving Risk Stratification in pT3 Upper Tract Urothelial Carcinoma: A Focus on Invasion Patterns

## TL;DR

This study introduces a new way to classify a type of kidney and ureter cancer based on how the tumor spreads, which helps doctors better predict patient outcomes and tailor treatments.

## Contribution

A novel pT3 subclassification system for UTUC based on tumor invasion patterns into fat and kidney tissue.

## Key findings

- Tumors invading both fat and kidney tissue correlate with significantly poorer survival rates.
- Dual invasion is an independent predictor of worse overall, cancer-specific, and disease-free survival.
- The new classification system improves risk stratification for all UTUC locations.

## Abstract

This research introduces a refined method for categorizing pT3 upper tract urothelial carcinoma (UTUC), a type of cancer affecting the lining of the kidney and ureter. Traditional classifications have struggled to accurately predict patient outcomes due to inconsistencies and a focus primarily on renal pelvis tumors. This study, involving 120 patients from Taiwan, proposes a new system that considers the specific patterns of tumor invasion: whether the cancer has spread into the surrounding fat, the kidney tissue itself, or both. The key finding is that tumors invading both fat and kidney tissue significantly correlate with poorer survival rates. This dual invasion pattern was identified as an independent predictor of worse overall survival, cancer-specific survival, and disease-free survival. In essence, patients with this specific invasion pattern face a higher risk. This new classification system, applicable to all UTUC locations, aims to provide a more precise tool for doctors to assess patient risk and tailor treatment strategies. By improving risk stratification, clinicians can make more informed decisions, potentially leading to better patient outcomes and more effective cancer management.

Purpose: Existing T3 subclassifications for upper tract urothelial cancer (UTUC) are limited by heterogeneity and a primary focus on renal pelvis tumors. Our study aimed to propose a novel pT3 subclassification system specifically tailored to pT3 UTUC patients. Materials and Methods: This study analyzed 120 pT3 UTUC cases from a Taiwanese multicenter registry, using a standardized pathology report and a single pathologist for evaluation. Results: Univariate analysis revealed survival differences based on existing subclassifications. Multivariate analysis identified concurrent fat and parenchyma invasion as an independent predictor of worse overall survival (OS), cancer-specific survival (CSS), and disease-free survival (DFS). Conclusions: This study proposes a novel pT3 subclassification incorporating fat and parenchyma invasion, applicable to all UTUC sites. This subclassification may improve risk stratification, guide treatment decisions, and ultimately enhance patient outcomes.